EUVIMEDEUVIMED entdecken
Crossref

Eosinophil Depletion as a Potential Therapeutic Strategy in Acute and Chronic Intestinal Inflammation Based on a Dextran Sulfate Sodium Colitis Model

Inge Jacobs iD, Sara Deleu, Jonathan Cremer, Gert De Hertogh, Séverine Vermeire, Christine Breynaert, Tim Vanuytsel, Bram Verstockt iD

Inflammatory Bowel Diseases · 2025

DOI: 10.1093/ibd/izae168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Inge Jacobs und 7 weiteren Autor:innen. Beteiligte Einrichtung: Allergy and Clinical Immunology Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Dextran Sulfate, Mice, Inbred C57BL, Disease Models, Animal, Eosinophils. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: BIRD, Flanders Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A role for eosinophils in intestinal inflammation and fibrosis in the context of inflammatory bowel disease has been suggested, yet the precise nature, whether causal or secondary remains debated. Hence, it remains unclear whether targeting eosinophils should be further explored as a treatment option in inflammatory bowel disease.

Methods

Acute and chronic dextran sulfate sodium colitis was induced in wild-type C57BL/6 mice. Eosinophils were depleted by anti-CCR3 injections before colitis induction in a chronic model and after colitis onset in an acute model in order to investigate the impact of eosinophil depletion on pre-existing colitis. Inflammation was assessed using the disease activity index, macroscopic damage, and histological disease activity score. In the chronic model, fibrosis was assessed by examining colon weight/length ratio, collagen deposition through Martius Scarlet Blue staining, hydroxyproline assay, and COL1A1 expression. Protein and gene expression were assessed using the Meso Scale Discovery platform and real-time quantitative polymerase chain reaction.

Results

In the acute and chronic colitis model, eosinophil depletion resulted in reduced disease activity and faster recovery, as observed via the total area under the curve of the disease activity index (P = .004 and P = .02, respectively), macroscopic damage score (P = .009 and P = .08, respectively), and histological disease activity score (P = .09 and P = .002, respectively). In the acute model, the accelerated recovery was accompanied by an increase in interleukin (IL)-10 (P = .03) and a decrease in IL-4 (P = .03) and IL-6 (P = .009). Colon weight/length ratio and collagen deposition were not affected by eosinophil depletion.

Conclusions

Eosinophil depletion prevents and decreases intestinal inflammation in a preclinical dextran sulfate sodium model without affecting fibrosis. These results pave the way for exploring eosinophil depletion as a novel treatment modality in addressing intestinal inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dextran SulfateMice, Inbred C57BLDisease Models, AnimalEosinophilsColitisAnimalsMiceChronic DiseaseAcute DiseaseFibrosisMaleInflammationColon

Substanzen

Dextran Sulfate

Autor:innen und Institutionen

  • Allergy and Clinical Immunology Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
  • Translational Research Centre for Gastrointestinal Disorders, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
  • Translational Cell & Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
  • Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium.
  • Department of General Internal Medicine, UZ Leuven, Leuven, Belgium.

ORCID-Profile: Inge Jacobs, Bram Verstockt

Förderung

  • BIRD
  • Flanders Research Foundation

Zitieren

APA

Jacobs, I., Deleu, S., Cremer, J., De Hertogh, G., Vermeire, S., Breynaert, C., Vanuytsel, T., & Verstockt, B. (2025). Eosinophil Depletion as a Potential Therapeutic Strategy in Acute and Chronic Intestinal Inflammation Based on a Dextran Sulfate Sodium Colitis Model. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae168

Vancouver

Jacobs I, Deleu S, Cremer J, De Hertogh G, Vermeire S, Breynaert C, et al. Eosinophil Depletion as a Potential Therapeutic Strategy in Acute and Chronic Intestinal Inflammation Based on a Dextran Sulfate Sodium Colitis Model. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae168

BibTeX
@article{Jacobs2025,
  author = {Jacobs, Inge and Deleu, Sara and Cremer, Jonathan and De Hertogh, Gert and Vermeire, Séverine and Breynaert, Christine and Vanuytsel, Tim and Verstockt, Bram},
  title = {Eosinophil Depletion as a Potential Therapeutic Strategy in Acute and Chronic Intestinal Inflammation Based on a Dextran Sulfate Sodium Colitis Model},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  doi = {10.1093/ibd/izae168}
}
Kostenlos starten →